Fei W - Search Results

1

Unraveling the Plasma Protein Corona by Ultrasonic Cavitation Augments Active-Transporting of Liposome in Solid Tumor.

Wang G, Jiang Y, Xu J, Shen J, Lin T, Chen J, Fei W, Qin Y, Zhou Z, Shen Y, Huang P. Wang G, et al. Among authors: fei w. Adv Mater. 2023 Mar;35(9):e2207271. doi: 10.1002/adma.202207271. Epub 2023 Jan 1. Adv Mater. 2023. PMID: 36479742

2

Perturbing plasma membrane lipid: a new paradigm for tumor nanotherapeutics.

Fei W, Yan J, Wu X, Yang S, Zhang X, Wang R, Chen Y, Xu J, Zheng C. Fei W, et al. Theranostics. 2023 Apr 23;13(8):2471-2491. doi: 10.7150/thno.82189. eCollection 2023. Theranostics. 2023. PMID: 37215569 Free PMC article. Review.

3

Enzyme-activatable kidney-targeted dendrimer-drug conjugate for efficient childhood nephrotic syndrome therapy.

Chen D, Xu J, Lv S, Jin X, Chen Y, Cai H, Wang Q, Xuan X, Wang G, Fei W, Chen J. Chen D, et al. Among authors: fei w. Theranostics. 2024 Oct 21;14(18):6991-7006. doi: 10.7150/thno.101606. eCollection 2024. Theranostics. 2024. PMID: 39629125 Free PMC article.

4

Biological protein mediated ferroptotic tumor nanotherapeutics.

Tao J, Li C, Zheng Y, Wang F, Zhang M, Wu X, Chen Y, Zeng Q, Chen F, Fei W. Tao J, et al. Among authors: fei w. J Mater Chem B. 2021 Nov 24;9(45):9262-9284. doi: 10.1039/d1tb01289d. J Mater Chem B. 2021. PMID: 34730601 Review.

5

Combat Against Gynecological Cancers with Blood Vessels as Entry Point: Anti-Angiogenic Drugs, Clinical Trials and Pre-Clinical Nano-Delivery Platforms.

Yang S, Fei W, Zhao Y, Wang F, Ye Y, Wang F. Yang S, et al. Among authors: fei w. Int J Nanomedicine. 2023 Jun 8;18:3035-3046. doi: 10.2147/IJN.S411761. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37312935 Free PMC article. Review.

6

Regulating Cholesterol in Tumorigenesis: A Novel Paradigm for Tumor Nanotherapeutics.

Wu H, Wu X, Zhao M, Yan J, Li C, Zhang Z, Tang S, Wang R, Fei W. Wu H, et al. Among authors: fei w. Int J Nanomedicine. 2024 Feb 1;19:1055-1076. doi: 10.2147/IJN.S439828. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38322754 Free PMC article. Review.

7

Nanotechnology-integrated ferroptosis inducers: a sharp sword against tumor drug resistance.

Li C, Wu X, Zheng C, Xu S, Liu Y, Qin J, Fan X, Ye Y, Fei W. Li C, et al. Among authors: fei w. J Mater Chem B. 2022 Oct 5;10(38):7671-7693. doi: 10.1039/d2tb01350a. J Mater Chem B. 2022. PMID: 36043505 Review.

8

Emerging bioengineering breakthroughs in precision diagnosis and therapy for endometriosis and adenomyosis.

Peng Y, Zhang M, Yan J, Wang R, Xin Y, Zheng X, Zhu L, Fei W, Zhao M. Peng Y, et al. Among authors: fei w. J Mater Chem B. 2025 Jan 15;13(3):742-762. doi: 10.1039/d4tb01755b. J Mater Chem B. 2025. PMID: 39717994 Review.

9

Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy.

Fei W, Zhao Y, Wu X, Sun D, Yao Y, Wang F, Zhang M, Li C, Qin J, Zheng C. Fei W, et al. J Nanobiotechnology. 2021 Jun 15;19(1):184. doi: 10.1186/s12951-021-00931-3. J Nanobiotechnology. 2021. PMID: 34130695 Free PMC article.

10

Targeted GSH-exhausting and hydroxyl radical self-producing manganese-silica nanomissiles for MRI guided ferroptotic cancer therapy.

Fei W, Chen D, Tang H, Li C, Zheng W, Chen F, Song Q, Zhao Y, Zou Y, Zheng C. Fei W, et al. Nanoscale. 2020 Aug 20;12(32):16738-16754. doi: 10.1039/d0nr02396e. Nanoscale. 2020. PMID: 32578659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters